Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.

Mol Genet Metab Rep · 2018 · PMC5852296 · PMID 29552494

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, only 8 patients participated in this trial, which was less than originally expected and insufficient to perform statistical analyses, even if there was a clear trend in some endpoints.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.